title: Cardiac allograft cellular rejection during OKT3 prophylaxis in the absence of sensitization.
authors.affiliation: Utah Transplantation Affiliated Hospitals, Cardiac Transplant Program, Salt Lake City.
authors.forename: C K
authors.initials: CK
authors.lastname: Moore
authors.forename: J B
authors.initials: JB
authors.lastname: O'Connell
authors.forename: D G
authors.initials: DG
authors.lastname: Renlund
authors.forename: M R
authors.initials: MR
authors.lastname: Bristow
authors.forename: E H
authors.initials: EH
authors.lastname: Hammond
mesh_terms: D000911:Antibodies, Monoclonal / Q000097:blood / Q000627:therapeutic use*; D005260:Female; D006084:Graft Rejection; D016027:Heart Transplantation / Q000276:immunology / Q000379:methods* / Q000473:pathology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3; D009206:Myocardium / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3